NGM Biopharmaceuticals Inc
NGMDelisted Apr 5, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001426332
NGM Biopharmaceuticals Inc was delisted on Apr 5, 2024; its insiders filed their last Form 4 on Apr 8, 2024; 75 institutions reported holding it in 13F filings for Q1 2024, worth $55.1M in total; no superinvestor held it.
Holders of 5% or more of NGM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of NGM Biopharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of NGM Biopharmaceuticals Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on NGM Biopharmaceuticals Inc, newest first.
No Schedule 13D or 13G filings on NGM Biopharmaceuticals Inc are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell NGM Biopharmaceuticals Inc shares.
No Form 144 notices for NGM Biopharmaceuticals Inc are on file.